Hillcrest Wealth Advisors’s Traws Pharma TRAW Stock Holding History

Hillcrest Wealth Advisors’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-669	Closed	-$12.5K	–	49
2023 Q4	$12.5K	Hold	669	–	–	0.01%	45
2023 Q3	$11.9K	Hold	669	–	–	0.01%	47
2023 Q2	$19.7K	Hold	669	–	–	0.01%	47
2023 Q1	$12.2K	Hold	669	–	–	0.01%	48
2022 Q4	$10.8K	Hold	669	–	–	0.01%	50
2022 Q3	$15K	Hold	669	–	–	0.01%	52
2022 Q2	$22K	Hold	669	–	–	0.01%	50
2022 Q1	$31K	Hold	669	–	–	0.02%	48
2021 Q4	$43K	Hold	669	–	–	0.02%	52
2021 Q3	$64K	Buy	669 +1	+0.1%	+$129	0.04%	52
2021 Q2	$116K	Sell	668 -1	-0.1%	-$226	0.07%	51
2021 Q1	$251K	Hold	669	–	–	0.15%	46
2020 Q4	$117K	Hold	669	–	–	0.08%	51
2020 Q3	$70K	Hold	669	–	–	0.05%	59
2020 Q2	$142K	Hold	669	–	–	0.12%	43
2020 Q1	$76K	Hold	669	–	–	0.08%	40
2019 Q4	$96K	Buy	+669	New	+$125K	0.08%	38

Other funds holding TRAW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hillcrest Wealth Advisors's TRAW Position: Q1 2024 in Review

Hillcrest Wealth Advisors sold out of Traws Pharma (TRAW) in Q1 2024, closing a stake of 669 shares — an estimated $12.5K sold.

Hillcrest Wealth Advisors first reported a position in TRAW in Q4 2019 and held it in 17 quarters. The position peaked at $251K in Q1 2021. 24 funds tracked by Wall St. Rank hold TRAW as of Q1 2024.

Hillcrest Wealth Advisors reported no remaining Traws Pharma position as of Q1 2024 after selling out during the quarter.
Hillcrest Wealth Advisors sold 669 Traws Pharma shares in Q1 2024, an estimated $12.5K.
Hillcrest Wealth Advisors first reported a position in Traws Pharma in Q4 2019 and held it in 17 quarters.
Hillcrest Wealth Advisors's Traws Pharma position peaked at $251K in Q1 2021.
24 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2024.

Based on Hillcrest Wealth Advisors's 13F filing for Q1 2024, filed 11 Apr 2024.